Eli Lilly and Co (NYSE:LLY)

323.05
Delayed Data
As of 4:00pm ET
 +5.43 / +1.71%
Today’s Change
220.20
Today|||52-Week Range
330.85
+16.95%
Year-to-Date
Top Analyst Reports for Meta Platforms, Eli Lilly & Home Depot
2:44pm / Zacks.com - Paid Partner Content
LabCorp (LH) Partners HealthVerity to Grow in Drug Development
Jun 22 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Gains As Market Dips: What You Should Know
Jun 27 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
Jun 20 / Zacks.com - Paid Partner Content
Radius (RDUS) to Go Private With $890M Deal, Shares Gain
Jun 24 / Zacks.com - Paid Partner Content
LabCorp (LH) Gets FDA Nod for VirSeq SARS-CoV-2 NGS Test
Jun 20 / Zacks.com - Paid Partner Content
Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug
Jun 23 / Zacks.com - Paid Partner Content
Why Eli Lilly's Immunology Prospects Look Promising
Jun 20 / MotleyFool.com - Paid Partner Content
LLY's New Drug Lineup Looks Promising For Investors
Jun 23 / StockNews.com - Paid Partner Content
The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna
Jun 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close317.62
Today’s open319.37
Day’s range317.68 - 324.56
Volume2,562,100
Average volume (3 months)3,061,177
Market cap$309.4B
Data as of 4:00pm ET, 06/29/2022

Growth & Valuation

Earnings growth (last year)-9.81%
Earnings growth (this year)+2.55%
Earnings growth (next 5 years)+16.27%
Revenue growth (last year)+15.40%
P/E ratio48.0
Price/Sales8.89
Price/Book34.58

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.28+0.55%
ABBVAbbVie+1.51+0.99%
MRKMerck+0.86+0.94%
AZNAstraZeneca+0.96+1.46%
Data as of 5:40pm ET, 06/29/2022

Financials

Next reporting dateAugust 4, 2022
EPS forecast (this quarter)$1.73
Annual revenue (last year)$28.3B
Annual profit (last year)$5.6B
Net profit margin19.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Indianapolis, Indiana

Forecasts